FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09).
"The progress and momentum we achieved during 2018 have continued into 2019," stated Brian Lian, Ph.D., chief executive officer of Viking Therapeutics. "At the recent EASL conference, we... More

